Tami Martin, R.N.
2018
Compensation breakdown
Non-Equity Incentive Plan | $98,622 |
---|---|
Option Awards | $278,326 |
Salary | $307,661 |
Other | $40,430 |
Total | $725,039 |
RN received $307.7K in salary, accounting for 42% of the total pay in 2018.
RN also received $98.6K in non-equity incentive plan, $278.3K in option awards and $40.4K in other compensation.
Rankings
In 2018, Tami Martin, R.N.'s compensation ranked 10,564th out of 14,244 executives tracked by ExecPay. In other words, RN earned more than 25.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,564 | 26th |
Manufacturing | 4,252 | 26th |
Chemicals And Allied Products | 1,602 | 25th |
Drugs | 1,353 | 26th |
Pharmaceutical Preparations | 1,042 | 25th |
Pay ratio
Tami Martin, R.N.'s Pay | $725,039 |
---|---|
Median Employee's Pay | $131,026 |
Pay Ratio | to 1 |
In 2018, the annual total compensation of Tami Martin, R.N. was $725,039.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $131,026.
The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore to one.
RN's colleagues
We found five more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2018.
2018
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
2018
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
2018
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2018
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
2018
Victor Vaughn
Supernus Pharmaceuticals